Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis
Austin M, Quesenberry PJ, Ventetuolo CE, Liang O, Reagan JL. Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis. Clinical Lymphoma Myeloma & Leukemia 2019, 19: 593-597. PMID: 31262666, PMCID: PMC6814397, DOI: 10.1016/j.clml.2019.05.009.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overBiomarkersBiopsyEchocardiographyEpithelial-Mesenchymal TransitionFemaleHumansHypertension, PulmonaryMaleMiddle AgedPrevalencePrimary MyelofibrosisPrognosisRetrospective StudiesSurvival AnalysisConceptsPulmonary hypertensionSecondary myelofibrosisOverall survivalMF patientsPrimary myelofibrosisSingle-center retrospective chart reviewGroup 5 pulmonary hypertensionImpact of PHInfluence of PHPresence of PHChronic obstructive pulmonary diseaseRetrospective patient databaseIntermediate-risk patientsRetrospective chart reviewObstructive pulmonary diseaseBone marrow fibrosisPathogenesis of myelofibrosisMF cohortRoutine echoConstitutional symptomsChart reviewRisk patientsPulmonary diseaseTransthoracic echoMarrow fibrosis